Andrew Fenning

Reversal of cardiac dysfunction by selective ET-A receptor antagonism (2005)

Allan, Anthony, Fenning, Andrew, Levick, Scott, Hoey, Andrew, Brown, Lindsay

1. The effectiveness of a selective endothelin receptor-A (ET-A) antagonist, A-127722 (approximately 10 mg kg-1 day-1 as 200 mg kg-1 powdered food), to reverse existing cardiac remodelling and...

Reversal of cardiac dysfunction by selective ET-A receptor antagonism (2005)

Allan, Anthony, Fenning, Andrew, Levick, Scott, Hoey, Andrew, Brown, Lindsay

1. The effectiveness of a selective endothelin receptor-A (ET-A) antagonist, A-127722 (approximately 10 mg kg-1 day-1 as 200 mg kg-1 powdered food), to reverse existing cardiac remodelling and...

Reversal of cardiac dysfunction by selective ET-A receptor antagonism (2005)

Allan, Anthony, Fenning, Andrew, Levick, Scott, Hoey, Andrew, Brown, Lindsay

1. The effectiveness of a selective endothelin receptor-A (ET-A) antagonist, A-127722 (approximately 10 mg kg-1 day-1 as 200 mg kg-1 powdered food), to reverse existing cardiac remodelling and...

Reversal of cardiac dysfunction by selective ET-A receptor antagonism (2005)

Allan, Anthony, Fenning, Andrew, Levick, Scott, Hoey, Andrew, Brown, Lindsay

1. The effectiveness of a selective endothelin receptor-A (ET-A) antagonist, A-127722 (approximately 10 mg kg-1 day-1 as 200 mg kg-1 powdered food), to reverse existing cardiac remodelling and...

L-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats (2005)

Hoey, Andrew, Fenning, Andrew, Harrison, Glenn, Rose Meyer, Roselyn, Brown, Lindsay

Nitric oxide (NO) is essential for normal function of the cardiovascular system. This study has determined whether chronic administration of L-arginine, the biological precursor of NO, attenuates the...

L-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats (2005)

Hoey, Andrew, Fenning, Andrew, Harrison, Glenn, Rose Meyer, Roselyn, Brown, Lindsay

Nitric oxide (NO) is essential for normal function of the cardiovascular system. This study has determined whether chronic administration of L-arginine, the biological precursor of NO, attenuates the...

L-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats (2005)

Hoey, Andrew, Fenning, Andrew, Harrison, Glenn, Rose Meyer, Roselyn, Brown, Lindsay

Nitric oxide (NO) is essential for normal function of the cardiovascular system. This study has determined whether chronic administration of L-arginine, the biological precursor of NO, attenuates the...

L-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats (2005)

Hoey, Andrew, Fenning, Andrew, Harrison, Glenn, Rose Meyer, Roselyn, Brown, Lindsay

Nitric oxide (NO) is essential for normal function of the cardiovascular system. This study has determined whether chronic administration of L-arginine, the biological precursor of NO, attenuates the...

L-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats. (2005)

Fenning, Andrew, Harrison, Glenn, Rose'Meyer, Roselyn, Hoey, Andrew, Brown, Lindsay

Nitric oxide (NO) is essential for the normal functioning of the cardiovascular system. This study has determined whether chronic administration of L-arginine, the biological precursor of NO,...

L-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats. (2005)

Fenning, Andrew, Harrison, Glenn, Rose'Meyer, Roselyn, Hoey, Andrew, Brown, Lindsay

Nitric oxide (NO) is essential for the normal functioning of the cardiovascular system. This study has determined whether chronic administration of L-arginine, the biological precursor of NO,...

Reversal of cardiac dysfunction by selective ET-A receptor antagonism (2005)

Allan, Anthony, Fenning, Andrew, Levick, Scott, Hoey, Andrew, Brown, Lindsay

1. The effectiveness of a selective endothelin receptor-A (ET-A) antagonist, A-127722 (approximately 10 mg kg-1 day-1 as 200 mg kg-1 powdered food), to reverse existing cardiac remodelling and...

L-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats (2005)

Hoey, Andrew, Fenning, Andrew, Harrison, Glenn, Rose Meyer, Roselyn, Brown, Lindsay

Nitric oxide (NO) is essential for normal function of the cardiovascular system. This study has determined whether chronic administration of L-arginine, the biological precursor of NO, attenuates the...

L-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats. (2005)

Fenning, Andrew, Harrison, Glenn, Rose'Meyer, Roselyn, Hoey, Andrew, Brown, Lindsay

Nitric oxide (NO) is essential for the normal functioning of the cardiovascular system. This study has determined whether chronic administration of L-arginine, the biological precursor of NO,...

L-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats. (2005)

Fenning, Andrew, Harrison, Glenn, Rose'Meyer, Roselyn, Hoey, Andrew, Brown, Lindsay

Nitric oxide (NO) is essential for the normal functioning of the cardiovascular system. This study has determined whether chronic administration of L-arginine, the biological precursor of NO,...

Reversal of cardiac dysfunction by selective ET-A receptor antagonism (2005)

Allan, Anthony, Fenning, Andrew, Levick, Scott, Hoey, Andrew, Brown, Lindsay

1. The effectiveness of a selective endothelin receptor-A (ET-A) antagonist, A-127722 (approximately 10 mg kg-1 day-1 as 200 mg kg-1 powdered food), to reverse existing cardiac remodelling and...

L-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats (2005)

Hoey, Andrew, Fenning, Andrew, Harrison, Glenn, Rose Meyer, Roselyn, Brown, Lindsay

Nitric oxide (NO) is essential for normal function of the cardiovascular system. This study has determined whether chronic administration of L-arginine, the biological precursor of NO, attenuates the...

Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats

Mirkovic, Stevo, Seymour, Anne-Marie L, Fenning, Andrew, Strachan, Anna, Margolin, Solomon B, Taylor, Stephen M, ...

This study has administered pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone) or amiloride to attenuate the remodelling and associated functional changes, especially an increased cardiac stiffness, in...

Reversal of cardiac dysfunction by selective ET-A receptor antagonism

Allan, Anthony, Fenning, Andrew, Levick, Scott, Hoey, Andrew, Brown, Lindsay

The effectiveness of a selective endothelin receptor-A (ET-A) antagonist, A-127722 (approximately 10 mg kg−1 day−1 as 200 mg kg−1 powdered food), to reverse existing cardiac...